Towards precision medicine strategies using plasma proteomic profiling for suspected gallbladder cancer: A pilot study
This study highlights the potential of plasma proteomic profiling to significantly improve the preoperative diagnostic accuracy of gallbladder cancer <i>vs.</i> cholecystitis. Using machine learning models, we identified biologically relevant plasma proteins associated with the diagnosis of gall bladder cancer. A noninvasive preoperative test based on selected plasma proteins could potentially enhance clinical decision-making, reduce unnecessary surgeries, and mitigate the associated risks for patients with suspected GBC, marking a step forward in precision medicine.
Authors
- Annika Bergquist (ORCID: https://orcid.org/0000-0002-3858-6241)
- Martin Cornillet (ORCID: https://orcid.org/0000-0001-7981-0927)
- Ernesto Sparrelid (ORCID: https://orcid.org/0000-0003-0259-8328)
- Hannes Jansson (ORCID: https://orcid.org/0000-0002-1833-854X)
- Ghada Nouaïria (ORCID: https://orcid.org/0000-0003-0081-7347)
Institutions
- Karolinska Institutet (SE)
Publication Details
- Journal
- JHEP Reports
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1016/j.jhepr.2025.101365
- Citations
- 1
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Svenska Sällskapet för Medicinsk Forskning
- Karolinska Institutet
- Center for Innovative Medicine